Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Pharmacogenetics of CYP3A5 in Pediatric Patients With Eosinophilic Esophagitis.
Journal: Clinical and translational science
Published: August 20, 2025
A post hoc analysis of linaclotide in pediatric patients with functional constipation and neurodevelopmental disorders.
Journal: Journal of pediatric gastroenterology and nutrition
Published: July 04, 2025
Exploring the Influence of Obesity and CYP2 C19 Genotype on Lansoprazole Pharmacokinetics in Pediatric Patients: A Population Modeling Approach.
Journal: Clinical pharmacokinetics
Published: April 23, 2025
Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis.
Journal: Metabolites
Published: July 29, 2024
Resting Energy Expenditure Equations Have Lower Accuracy for Adolescents with Overweight/Obesity Versus Healthy-Weight Adolescents.
Journal: Childhood obesity (Print)
Published: July 25, 2024
Evaluation of Obesity-Related Physiological Changes on Pantoprazole Clearance in Children Using a Population Pharmacokinetic Approach.
Journal: Journal of clinical pharmacology
Published: June 24, 2024
Metabolomic comparison of postprandial distress syndrome patients with and without duodenal eosinophilia.
Journal: Journal of pediatric gastroenterology and nutrition
Published: May 20, 2024
Delta-S-Cys-Albumin as a Marker of Pediatric Biospecimen Integrity.
Journal: Biopreservation and biobanking
Published: April 23, 2024
Safety and efficacy of linaclotide in children aged 2-5 years with functional constipation: Phase 2, randomized study.
Journal: Journal of pediatric gastroenterology and nutrition
Published: February 01, 2024
Physiologically-based pharmacokinetic modeling of pantoprazole to evaluate the role of CYP2C19 genetic variation and obesity in the pediatric population.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 19, 2024
Last Updated: 09/26/2026